Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab

Download

Analysis of SKOV3 ovarian cancer xenograft tumors treated with trastuzumab (TZ), pertuzumab (PZ), or both. TZ and PZ target Human Epidermal Growth Factor Receptor 2 (HER2). Combined therapy results in enhanced antitumor activity. Results provide insight into the molecular basis of this enhancement.

Cancer Type: Ovarian Cancer

GPL: 6947

Number of Genes with Data: 948

Number Observations: 23

Number Outputs: 1

Imbalanced Ratio: 0.833333333

Default Task: Classification